Ascendis Pharma A (ASND) EBITDA Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
35,025.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
35,025.00 |
| Dec 31, 2025 |
-15.17 Mn |
| Sep 30, 2025 |
14,197.00 |
| Jun 30, 2025 |
27,834.00 |
| Mar 31, 2025 |
4,277.00 |
| Dec 31, 2024 |
15.17 Mn |
| Sep 30, 2024 |
16,528.00 |
| Jun 30, 2024 |
-4,544.00 |
| Mar 31, 2024 |
19,597.00 |
| Dec 31, 2023 |
62,869.00 |
| Sep 30, 2023 |
78,290.00 |
| Jun 30, 2023 |
107,403.00 |
| Mar 31, 2023 |
149,921.00 |
| Dec 31, 2022 |
-49,863.00 |
| Sep 30, 2022 |
600,833.00 |
| Jun 30, 2022 |
1.18 Mn |
| Mar 31, 2022 |
633,848.00 |
| Dec 31, 2021 |
-11,508.00 |
| Sep 30, 2021 |
-270,934.00 |
| Jun 30, 2021 |
-651,951.00 |
